Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

15
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
15
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

9
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas
  1. Home
  2. Cardiomiopatía Dilatada: Causas, Mecanismos Y Enfoques De Tratamiento Actuales Y Futuros
  1. Home
  2. Cardiomiopatía Dilatada: Causas, Mecanismos Y Enfoques De Tratamiento Actuales Y Futuros

Video Experimental Relacionado

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.6K

Cardiomiopatía dilatada: causas, mecanismos y enfoques de tratamiento actuales y futuros

Stephane Heymans1, Neal K Lakdawala2, Carsten Tschöpe3

  • 1Department of Cardiology, Cardiovascular Research Institute Maastricht, University of Maastricht & Maastricht University Medical Centre, Maastricht, Netherlands; Department of Cardiovascular Sciences, Centre for Vascular and Molecular Biology, KU Leuven, Leuven, Belgium.

Lancet (London, England)
|September 16, 2023

Ver abstracta en PubMed

Resumen
Este resumen es generado por máquina.

La miocardiopatía dilatada, una enfermedad del músculo cardíaco, tiene causas que incluyen genética y factores adquiridos como infecciones o toxinas. El diagnóstico y el tratamiento deben considerar tanto las mutaciones genéticas como los desencadenantes adquiridos para obtener mejores resultados para los pacientes.

Más Videos Relacionados

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

9.8K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

5.8K

Videos de Experimentos Relacionados

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.6K
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

9.8K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

5.8K

Área de la Ciencia:

  • Cardiología
  • La genética
  • Fisiopatología

Sus antecedentes:

  • La miocardiopatía dilatada (DCM) implica el agrandamiento del músculo cardíaco y la función deteriorada.
  • La definición convencional de DCM se considera demasiado restrictiva.
  • La DCM puede derivarse de factores genéticos (primarios) o adquiridos (secundarios).

Objetivo del estudio:

  • Revisar las actuales estrategias multidimensionales de diagnóstico y tratamiento de la DCM.
  • Para explorar la fisiopatología subyacente DCM para informar futuros tratamientos.
  • Resaltar la importancia de tener en cuenta tanto los factores genéticos como los adquiridos en la gestión del MDC.

Principales métodos:

  • Revisión de la literatura actual sobre el diagnóstico y tratamiento de la miocardiopatía dilatada.
  • Discusión de las etiologías genéticas y adquiridas de la DCM.
  • Exploración de los mecanismos fisiopatológicos que impulsan la progresión de la DCM.
  • Principales resultados:

    • Un porcentaje significativo (5-15%) de pacientes con DCM adquirida tiene variantes genéticas subyacentes.
    • Los enfoques diagnósticos y terapéuticos actuales deben integrar consideraciones genéticas y etiológicas adquiridas.
    • Los tratamientos futuros pueden estar dirigidos a mutaciones genéticas específicas o factores adquiridos como la inflamación y la fibrosis.

    Conclusiones:

    • El diagnóstico y el tratamiento de la miocardiopatía dilatada requieren un enfoque integral que aborde tanto las predisposiciones genéticas como los insultos adquiridos.
    • Comprender la diversa fisiopatología de la DCM es crucial para desarrollar terapias específicas y efectivas.
    • Es probable que las estrategias de tratamiento personalizadas para DCM evolucionen apuntando a vías moleculares y celulares específicas.